Management Board meeting: 16-17 March 2022

• Date:
  Mercoledì, 16 Marzo 2022, All day
• Sede:
  European Medicines Agency, Amsterdam, the Netherlands

Event summary

The Management Board is an integral governance body of the Agency. It has a supervisory role with general responsibility for budgetary and planning matters, the appointment of the Executive Director and the monitoring of the Agency's performance.

Documents

Agenda for the 115th meeting of the Management Board: 16-17 March 2022

Adopted Reference Number: EMA/MB/30014/2022

Minutes of the 115th meeting of the Management Board: 16-17 March 2022

Adopted Reference Number: EMA/MB/169135/2022

OPEN Pilot: One-year review and recommendations

Reference Number: EMA/6881/2022

Outcome of written procedures finalised during the period from 25 November 2021 to 18 February 2022

Reference Number: EMA/MB/149565/2022

Summary of transfers of appropriations in budgets 2021 and 2022

Reference Number: EMA/MB/58837/2022

2021 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission

Reference Number: EMA/719826/2021

Minor uses and minor species (MUMS)/limited market scheme for veterinary medicinal products - 12th annual report

Adopted Reference Number: EMA/573681/2021

2021 European Medicines Agency annual report on independence

Adopted Reference Number: EMA/759921/2021

Superseded - Composition of the Emergency Task Force (ETF) for the therapeutic response to the COVID-19 pandemic

Reference Number: EMA/555794/2021